Published in Arch Neurol on November 01, 2007
The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol (2010) 1.51
[Characteristics of anesthesia in patients with MELAS syndrome : Case report of anesthesia in video-assisted thoracoscopy]. Anaesthesist (2015) 1.22
Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J (2012) 0.96
Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A>G). J Inherit Metab Dis (2008) 0.95
Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases. Biochim Biophys Acta (2008) 0.90
Treatment of mitochondrial disorders. Curr Treat Options Neurol (2014) 0.90
Cardiological manifestations of mitochondrial respiratory chain disorders. Acta Myol (2011) 0.85
Mitochondrial disease heterogeneity: a prognostic challenge. Acta Myol (2014) 0.81
MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev (2016) 0.75
Atrio-His (James) accessory pathway and infiltration of γδ T cells in the heart with MELAS. BMJ Case Rep (2011) 0.75
Wolff-Parkinson-white syndrome in a patient with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes syndrome. Korean Circ J (2011) 0.75
A Case of Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome with Intracardiac Thrombus [corrected]. Korean Circ J (2013) 0.75
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci (2008) 2.39
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord (2007) 2.17
Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. J Pediatr (2007) 2.05
The motor neuron response to SMN1 deficiency in spinal muscular atrophy. Muscle Nerve (2014) 2.02
Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet (2002) 1.83
Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol (2005) 1.77
Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet A (2004) 1.64
A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet (2006) 1.63
Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr (2007) 1.55
Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet (2006) 1.53
Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 1.45
Experience with the Awaji Island modifications to the ALS diagnostic criteria. Muscle Nerve (2010) 1.43
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr Phys Ther (2011) 1.42
The spectrum of movement disorders in Glut-1 deficiency. Mov Disord (2010) 1.33
Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep (2013) 1.32
Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol (2011) 1.32
Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology (2012) 1.31
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. Am Heart J (2005) 1.30
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol (2011) 1.21
Missed opportunities for duchenne muscular dystrophy. J Pediatr (2009) 1.21
A functionally dominant mitochondrial DNA mutation. Hum Mol Genet (2008) 1.17
Nerve conduction abnormalities in patients with MELAS and the A3243G mutation. Arch Neurol (2006) 1.15
Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol (2009) 1.15
Common data elements for clinical research in Friedreich's ataxia. Mov Disord (2012) 1.14
Physical fitness and C-reactive protein level in children and young adults: the Columbia University BioMarkers Study. Pediatrics (2003) 1.12
GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol (2004) 1.12
Long QT syndrome due to a novel mutation in SCN5A: treatment with ICD placement at 1 month and left cardiac sympathetic denervation at 3 months of age. J Interv Card Electrophysiol (2009) 1.11
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol (2011) 1.08
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. PLoS One (2012) 1.08
Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox". J Neurol Sci (2004) 1.07
Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol (2009) 1.07
Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females. Arch Neurol (2010) 1.06
Spinal muscular atrophy. Neurotherapeutics (2008) 1.06
Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol (2002) 1.06
Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol (2006) 1.05
Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol (2005) 1.03
Mutation screening in patients with isolated cytochrome c oxidase deficiency. Pediatr Res (2003) 1.02
Carrier testing for spinal muscular atrophy. Genet Med (2010) 1.02
Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol (2005) 1.01
Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy. Neuromuscul Disord (2009) 1.01
Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants. J Biol Chem (2008) 1.01
Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia (2003) 0.98
Neonatal blood carnitine concentrations: normative data by electrospray tandem mass spectometry. Pediatr Res (2003) 0.96
Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. PLoS One (2012) 0.95
Efficiency perspectives on adaptive designs in stroke clinical trials. Stroke (2011) 0.94
Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers. Neurology (2014) 0.94
Scoliosis surgery in children with neuromuscular disease: findings from the US National Inpatient Sample, 1997 to 2003. Arch Neurol (2010) 0.94
Clinical application of whole-exome sequencing: a novel autosomal recessive spastic ataxia of Charlevoix-Saguenay sequence variation in a child with ataxia. JAMA Neurol (2013) 0.94
Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus. Circulation (2013) 0.94
Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord (2006) 0.93
Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.93
Coronary artery spasm during radiofrequency ablation of a left lateral accessory pathway. Pediatr Cardiol (2010) 0.93
Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes. Epilepsia (2012) 0.92
Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol (2011) 0.91
Congenital cutaneous hemangioma causing cardiac failure: a case report and review of the literature. Pediatr Dermatol (2012) 0.91
Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. Am J Hum Genet (2012) 0.91
Changes in glucose transport and water permeability resulting from the T310I pathogenic mutation in Glut1 are consistent with two transport channels per monomer. J Biol Chem (2002) 0.91
Load dependence of cardiac output in biventricular pacing: right ventricular pressure overload in pigs. J Thorac Cardiovasc Surg (2004) 0.90
Neonatal mitochondrial encephaloneuromyopathy due to a defect of mitochondrial protein synthesis. J Neurol Sci (2008) 0.90
Rapid atrial pacing: a useful technique during slow pathway ablation. Pacing Clin Electrophysiol (2007) 0.90
Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol (2002) 0.88
Clinical outcome measures in spinal muscular atrophy. J Child Neurol (2009) 0.88
Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet A (2009) 0.88
Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscul Disord (2010) 0.87
Murine Glut-1 transporter haploinsufficiency: postnatal deceleration of brain weight and reactive astrocytosis. Neurobiol Dis (2009) 0.87
Therapeutic developments in spinal muscular atrophy. Ther Adv Neurol Disord (2010) 0.87
A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol (2004) 0.87
Functional studies of threonine 310 mutations in Glut1: T310I is pathogenic, causing Glut1 deficiency. J Biol Chem (2003) 0.87
Mitochondrial myopathy and ophthalmoplegia in a sporadic patient with the G12315A mutation in mitochondrial DNA. Neuromuscul Disord (2002) 0.86
Elevated impedance during cardioversion in neonates with atrial flutter. Pediatr Cardiol (2009) 0.86
Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy. J Child Neurol (2010) 0.86
Infrastructure resources for clinical research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.85
Left-ventricular noncompaction in a pediatric population: predictors of survival. Pediatr Cardiol (2010) 0.85
Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy. J Child Neurol (2011) 0.85
Down syndrome: national conference on patient registries, research databases, and biobanks. Mol Genet Metab (2011) 0.85
Brain glucose supply and the syndrome of infantile neuroglycopenia. Arch Neurol (2007) 0.84
Mitochondrial disorders. J Child Neurol (2002) 0.83
Postmortem cardiomegaly and echocardiographic measurements of left ventricular size and function in children infected with the human immunodeficiency virus. The Prospective P2C2 HIV Multicenter Study. Cardiovasc Pathol (2003) 0.83
Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery. PLoS One (2007) 0.83
Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation. Arch Neurol (2010) 0.83
Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging Clin N Am (2003) 0.83
Classification of infantile seizures: implications for identification and treatment of inborn errors of metabolism. J Child Neurol (2002) 0.83
Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA). Neuromuscul Disord (2010) 0.82
SMA-MAP: a plasma protein panel for spinal muscular atrophy. PLoS One (2013) 0.82
Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol (2010) 0.82